Company / Free Cash Flow per Share
Bio-Rad Laboratories Free Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
$12.82
FY2025
5-year range
$2.71 / $17.75
FY2021-FY2025
Trend
+31.9%
vs FY2024
Sector context
#14 of 148
Health Care
What the data says
Among 148 Health Care companies, Bio-Rad Laboratories is in the top 9% for free cash flow per share. Free Cash Flow per Share has increased for 3 consecutive years, from $2.71 in FY2022 to $12.82 in FY2025.
Based on SEC 10-K filings.
12.82 in FY2025 with a 5-year CAGR of +20.0%. Top quartile in the Health Care sector.
Improved from $7.22 to $12.82 over the past 2 years.
Health Care sector context is included.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- +68.0%
- 5-Year CAGR
- +20.0%
- 10-Year CAGR
- -
Sector benchmark
+154.3% above sector average
Key checks
Key Insights
- Bio-Rad Laboratories's free cash flow per share has grown for 3 consecutive years.
- In FY2025, free cash flow per share increased 31.9% year-over-year.
- Ranks #14 out of 148 companies in the Health Care sector.
- Peak free cash flow per share was recorded in FY2021.
Company context
Key Data Points
- Strong return on equity: 23.0%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $12.82 | +31.9% |
| FY2024 | $9.72 | +34.6% |
| FY2023 | $7.22 | +167.0% |
| FY2022 | $2.71 | -84.8% |
| FY2021 | $17.75 | +244.6% |
| FY2020 | $5.15 | -57.0% |
| FY2019 | $11.97 | +375.3% |
| FY2018 | $2.52 | -0.2% |
| FY2017 | $2.52 | -51.7% |
| FY2016 | $5.23 | +103.6% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026